These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35215307)

  • 1. Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods.
    AlZahrani WM; AlGhamdi SA; Zughaibi TA; Rehan M
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods.
    AlZahrani WM; AlGhamdi SA; Sohrab SS; Rehan M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.
    Ajjarapu SM; Tiwari A; Taj G; Singh DB; Singh S; Kumar S
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):68. PubMed ID: 34727985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Date Palm (
    Zia Q; Rehman MT; Hashmi MA; Siddiqui S; Bin Dukhyil A; Ahmed MZ; Jamal A; Banawas S; Almalki SG; Owais M; Aldhafeeri HQ; Ibrahim IM; Alturaiki W; AlAjmi MF; Alsieni M; Alqurashi YE
    Front Neurosci; 2022; 16():915122. PubMed ID: 35958986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Inhibitors against Metastasis Protein "
    Mishra S; Singh S
    Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S742-S748. PubMed ID: 29491627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers.
    Adnan M; Koli S; Mohammad T; Siddiqui AJ; Patel M; Alshammari N; Bardakci F; Elasbali AM; Hassan MI
    OMICS; 2022 Aug; 26(8):461-470. PubMed ID: 35925819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational targeting of allosteric site of MEK1 by quinoline-based molecules.
    Singh R; Bhardwaj VK; Purohit R
    Cell Biochem Funct; 2022 Jul; 40(5):481-490. PubMed ID: 35604288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
    Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
    J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
    J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and drug-likeness of anti-cancer traditional Chinese medicine: molecular docking and molecular dynamics simulation study.
    Khan K; Albalawi K; Abbas MN; Burki S; Musad Saleh EA; Al Mouslem A; Alsaiari AA; A Zaki ME; Khan AU; Alotaibi G; Jalal K
    J Biomol Struct Dyn; 2024 Apr; 42(7):3295-3306. PubMed ID: 37279114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
    Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
    Bitew M; Desalegn T; Demissie TB; Belayneh A; Endale M; Eswaramoorthy R
    PLoS One; 2021; 16(12):e0260853. PubMed ID: 34890431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.